Subclinical hypothyroidism and hyperthyroidism. I: Prevalence and clinical relevanceWIERSINGA, W. M.Netherlands journal of medicine. 1995, Vol 46, Num 4, pp 197-204, issn 0300-2977Article

Is repeated fine-needle aspiration cytology indicated in (benign) thyroid nodules ?WIERSINGA, W. M.European journal of endocrinology. 1995, Vol 132, Num 6, pp 661-662, issn 0804-4643Article

Antithyroid action of carbocisteineWIERSINGA, W. M.British medical journal (1857). 1986, Vol 293, Num 6539, issn 0007-1447, 106Article

L-T4 and L-T3 combined treatment vs L-T4 aloneWIERSINGA, W. M.Annales d'endocrinologie. 2007, Vol 68, Num 4, pp 216-219, issn 0003-4266, 4 p.Conference Paper

Amiodarone induces a dose-dependent increase of plasma cholesterol in the ratWIERSINGA, W. M; BROENINK, M.Hormone and metabolic research. 1991, Vol 23, Num 2, pp 94-95, issn 0018-5043, 2 p.Article

Nuclear reverse T₃ binding sites: an artefact of isolation?HARTONG, R; WIERSINGA, W. M.Acta endocrinologica (Oslo). 1985, Vol 108, Num 4, pp 525-531, issn 0001-5598Article

Triiodothyronine affects the alternative splicing of thyroid hormone receptor alpha mRNATIMMER, D. C; BAKKER, O; WIERSINGA, W. M et al.Journal of endocrinology. 2003, Vol 179, Num 2, pp 217-225, issn 0022-0795, 9 p.Article

Interleukin-1β modulates endogenous thyroid hormone receptor α gene transcription in liver cellsKWAKKEL, J; WIERSINGA, W. M; BOELEN, A et al.Journal of endocrinology. 2007, Vol 194, Num 2, pp 257-265, issn 0022-0795, 9 p.Article

Tri-iodothyronine prevents the amiodarone-induced decrease in the expression of the liver low-density lipoprotein receptor geneHUDIG, F; BAKKER, O; WIERSINGA, W. M et al.Journal of endocrinology. 1997, Vol 152, Num 3, pp 413-421, issn 0022-0795Article

Differential involvement of nuclear factor-κB and activator protein-1 pathways in the interleukin-1β-mediated decrease of deiodinase type 1 and thyroid hormone receptor β1 mRNAKWAKKEL, J; WIERSINGA, W. M; BOELEN, A et al.Journal of endocrinology. 2006, Vol 189, Num 1, pp 37-44, issn 0022-0795, 8 p.Article

Childhood Graves' ophthalmopathy : results of a European questionnaire studyKRASSAS, G. E; SEGNI, M; WIERSINGA, W. M et al.European journal of endocrinology. 2005, Vol 153, Num 4, pp 515-520, issn 0804-4643, 6 p.Article

Decreased nocturnal surge of thyrotropin in nonthyroidal illnessROMIJN, J. A; WIERSINGA, W. M.The Journal of clinical endocrinology and metabolism. 1990, Vol 70, Num 1, pp 35-42, issn 0021-972X, 8 p.Article

PLA₂ activity in rat liver nucleiVAN DER KLIS, F. R. M; WIERSINGA, W. M.International journal of biochemistry. 1993, Vol 25, Num 4, pp 575-579, issn 0020-711XArticle

Amiodarone decreases gene expression of low-density lipoprotein receptor at both the mRNA and the protein levelHUDIG, F; BAKKER, O; WIERSINGA, W. M et al.Metabolism, clinical and experimental. 1998, Vol 47, Num 9, pp 1052-1057, issn 0026-0495Article

Inhibition of nuclear T3 binding via PLA₂-induced release of fatty acides from nuclear membranesVAN DER KLIS, F. R. M; WIERSINGA, W. M.Biochimica et biophysica acta. 1990, Vol 1047, Num 2, pp 131-134, issn 0006-3002, 4 p.Article

Current management of thyroid-associated ophthalmopathy in Europe. Results of an international surveyWEETMAN, A. P; WIERSINGA, W. M.Clinical endocrinology (Oxford. Print). 1998, Vol 49, Num 1, pp 21-28, issn 0300-0664Article

Sodium ipodate in the preparation of Graves' hyperthyroid patients for thyroidectomyBERGHOUT, A; WIERSINGA, W. M; BRUMMELKAMP, W. H et al.Hormone research. 1989, Vol 31, Num 5-6, pp 256-260, issn 0301-0163, 5 p.Article

Nuclear 3,5,3'-triiodothyronine receptor occupancy, phosphoenolpyruvate carboxykinase (PEPck) messenger ribonucleic acid levels and PEPck enzyme activity in rat liverHARTONG, R; WIERSINGA, W. M; LAMERS, W. H et al.Endocrinology (Philadelphia). 1987, Vol 120, Num 6, pp 2460-2467, issn 0013-7227Article

Goserelin-induced transient thyrotoxicosis in a hypothyroid woman on L-thyroxine replacementVAN BON, A. C; WIERSINGA, W. M.Netherlands journal of medicine. 2008, Vol 66, Num 6, pp 256-258, issn 0300-2977, 3 p.Article

Amiodarone and the thyroidWIERSINGA, W. M.Handbook of experimental pharmacology. 1997, Vol 128, pp 225-287, issn 0171-2004Article

Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNAHUDIG, F; BAKKER, O; WIERSINGA, W. M et al.FEBS letters. 1994, Vol 341, Num 1, pp 86-90, issn 0014-5793Article

Smoking and risk of Graves' diseasePRUMMEL, M. F; WIERSINGA, W. M.JAMA, the journal of the American Medical Association. 1993, Vol 269, Num 4, pp 479-482, issn 0098-7484Article

Amiodarone reduces the effect of T3 on beta adrenergic receptor density in rat heartHARTONG, R; WIERSINGA, W. M; PLOMP, T. A et al.Hormone and metabolic research. 1990, Vol 22, Num 2, pp 85-89, issn 0018-5043Article

Nuclear 3,5,3'-triiodothyronine receptor occupancy, phosphoenolpyruvate carboxykinase (PEPck) messenger ribonucleic acid levels and PEPck enzyme activity in rat liverHARTONG, R; WIERSINGA, W. M; LAMERS, W. H et al.Endocrinology (Philadelphia). 1987, Vol 120, Num 6, pp 2460-2467, issn 0013-7227Article

The future endocrine patient. Reflections on the future of clinical endocrinologyLAMBERTS, S. W. J; ROMIJN, J. A; WIERSINGA, W. M et al.European journal of endocrinology. 2003, Vol 149, Num 3, pp 169-175, issn 0804-4643, 7 p.Article